Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
106.2 USD | -2.45% | +4.10% | +6.77% |
Apr. 24 | Sector Update: Health Care Stocks Slipping Late Afternoon | MT |
Apr. 24 | Moderna to Collaborate With OpenAI to Launch New Generation of Medicines | MT |
Financials (USD)
Sales 2024 * | 4.21B | Sales 2025 * | 4.83B | Capitalization | 41.68B |
---|---|---|---|---|---|
Net income 2024 * | -2.81B | Net income 2025 * | -2.08B | EV / Sales 2024 * | 8.78 x |
Net cash position 2024 * | 4.73B | Net cash position 2025 * | 3.38B | EV / Sales 2025 * | 7.93 x |
P/E ratio 2024 * |
-15
x | P/E ratio 2025 * |
-20.5
x | Employees | 5,600 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 90.39% |
Latest transcript on Moderna, Inc.
1 day | -2.45% | ||
1 week | +4.10% | ||
Current month | -0.36% | ||
1 month | -3.81% | ||
3 months | +3.28% | ||
6 months | +38.33% | ||
Current year | +6.77% |
Managers | Title | Age | Since |
---|---|---|---|
Stéphane Bancel
CEO | Chief Executive Officer | 51 | 11-02-28 |
James Mock
DFI | Director of Finance/CFO | 47 | 22-09-05 |
Stephen Hoge
PSD | President | 48 | 12-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Paul Sagan
BRD | Director/Board Member | 65 | 18-05-31 |
Director/Board Member | 74 | 20-06-30 | |
Francois Nader
BRD | Director/Board Member | 67 | 19-12-10 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
5.66% | 0 M€ | 0.00% | - | |
4.69% | 2 M€ | -.--% | ||
4.08% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 106.2 | -2.45% | 2,744,580 |
24-04-24 | 108.8 | +0.89% | 3,410,216 |
24-04-23 | 107.9 | +3.28% | 2,435,253 |
24-04-22 | 104.5 | +3.01% | 3,176,356 |
24-04-19 | 101.4 | -0.58% | 2,670,446 |
Delayed Quote Nasdaq, April 25, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.77% | 41.68B | |
+1.12% | 43.84B | |
+45.26% | 41.25B | |
-11.96% | 27.04B | |
+6.01% | 25.53B | |
-24.92% | 18.18B | |
-3.63% | 12.29B | |
+27.16% | 12.29B | |
+7.30% | 11.15B | |
-18.79% | 9.98B |
- Stock Market
- Equities
- MRNA Stock